The Gurugram-based company is developing allogeneic CAR-NK cell therapies made from healthy donor cells, backed by a $4.2 million seed round and a government grant covering both resistant tumours and leishmaniasis.
The Gurugram-based company is developing allogeneic CAR-NK cell therapies made from healthy donor cells, backed by a $4.2 million seed round and a government grant covering both resistant tumours and leishmaniasis.
<iframe src="https://hindustansphere.com/embed/cluster/16fb451ef05166a0698f171a07cc310bfec05833" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="How East Ocyon Bio is building an off-the-shelf cancer cell therapy in Gurugram"></iframe>
